12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval

12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...

12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance

12/19/2024FDA Approves Betta/Xcovery's Ensartinib for NSCLC

12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China

12/16/2024Everest Medicines Announces Acceptance of the NDA for VELSIPITY

12/15/2024HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...

12/15/2024US-China Renew Science and Technology Pact Amid Rising Tensions

12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia

12/11/2024Generative AI Powers Insilico Medicine's Rapid Development of New IBD ...

12/10/2024Eisai's Dotinurad Approved in China for Gout

12/10/2024Huadong and Kiniksa's Rilonacept Gains Approval in China for Recurrent...

12/10/2024Sperogenix's Vamorolone Approved in China for DMD

12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...

12/10/2024Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...

12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...

12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...

12/10/2024Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...

12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024

12/8/2024ChipScreen Announces Mixed Phase III Results for Chiauranib in SCLC Tr...

12/8/2024BioNTech and DualityBio Unveil Promising Interim Results for Partnered...

12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...

12/5/2024Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...

12/5/2024Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...

12/4/2024Everest Medicines Announces Positive Results in Preliminary Analysis o...

12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...

12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...

12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  

12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...

12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong

Page:7/12 Total number of articles:340: [First][<<] [5] [6] [7] [8] [9] [>>] [End]